Jenne Kyle bought IONS
January 15, 2026 · Form 4 insider transaction
Jenne Kyle bought 9,675 shares of Ionis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,675
Price
$0.00
Total value
N/A
InsiderJenne Kyle
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2026
Filing dateJanuary 20, 2026
Shares owned after37,725
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.; Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.; Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.